Regulatory Updates

Latest News

tashatuvango-stock.adobe.com
FDA Approves Vafseo for Anemia in Kidney Disease

March 28th 2024

Vafseo, an oral therapy to treat patients with anemia due to chronic kidney, will be available in January 2025. About 40% of patients who could be treated with Vafseo have coverage through Medicare Advantage plans.

 FDA Approves Merck’s Drug for Pulmonary Arterial Hypertension
FDA Approves Merck’s Drug for Pulmonary Arterial Hypertension

March 26th 2024

FDA Approves Combination Therapy for Pulmonary Arterial Hypertension
FDA Approves Combination Therapy for Pulmonary Arterial Hypertension

March 25th 2024

LASZLO-stock.adobe.com
FDA Issues CRL for Odronextamab for Lymphoma Indications

March 25th 2024

FDA Grants Full Approval to Elahere
FDA Grants Full Approval to Elahere

March 25th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.